SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (895)11/17/1996 4:53:00 PM
From: richard davis   of 4342
 
Robin:

One point, I may be totally wrong about this, but if the results for AndroCar are replicated, then I think Paracelsian has found themselves the "silver bullet." Lets reexamine the data:

9 end stage cancer patients were selected for the compassionate testing. This means that their doctors did not believe a cure was possible, they had turned their cases over for experimental therapy. One died of chemotherapy poisoning (Thats all chemo is, pure poison). 4 were sent into remission. Thats unbelievable!!! I mean folks, these are terminal folks and you turned 50% around and put them into remission? Thats incredible!

The other folks developed reactions, none of which are in the same class as the reactions to radiation and chemotherapy. I stick by my assumptions: based on what I have read: AndroCar is better than AndroVir. If AndroVir is good in stopping to replicate the AIDS virus, AndroCar is better by putting end stage cancer patients into remission.

Robin, just my thoughts. I can't make heads or tails out of the stock drop, except for poor communications.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext